TickerFactsScreenerDevelopers

NORTHWEST BIOTHERAPEUTICS INC (NWBO) — Operating Income

Annual figures by fiscal year, from SEC filings.

2010: -$15.35M2011: -$26.79M2012: -$43.83M2013: -$55.47M2014: -$101.14M2015: -$126.28M2016: -$79.27M2017: -$54.68M2018: -$41.48M2019: -$27.98M2020: -$86.61M2021: -$52.70M2022: -$67.18M2023: -$55.51M2024: -$66.51M2025: -$59.91M-$59.91M
2010Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$59.91M+9.9%
2024-$66.51M-19.8%
2023-$55.51M+17.4%
2022-$67.18M-27.5%
2021-$52.70M+39.1%
2020-$86.61M-209.5%
2019-$27.98M+32.5%
2018-$41.48M+24.1%
2017-$54.68M+31.0%
2016-$79.27M+37.2%
2015-$126.28M-24.9%
2014-$101.14M-82.3%
2013-$55.47M-26.6%
2012-$43.83M-63.6%
2011-$26.79M-74.5%
2010-$15.35M—